2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists

S. Xu, J. Liu, X. Yang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Atypical presentation of psychogenic movement disorder with jaw-opening dystonia: Two cases reports

W.T. Yoon (Seoul, Korea)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Auditory cues during obstacle crossing increase gait asymmetry in neurologically health individuals but not in people with Parkinson’s disease

M.B. Pestana, L.T.B. Gobbi, L. Simieli, D. Orcioli-Silva, A.M. Baptista, V.S. Beretta, P.C.R. Santos, T. Penedo, V.I.A. Pereira, F.A. Barbieri (Rio Claro, Brazil)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Autophagic modulation by rosuvastatin prevent rotenone induced neurotoxicity as an in vitro model of Parkinson’s disease

W. Jang (Gangneung, Korea)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Axial prominent, delayed onset dystonia in cerebral palsy: Highlights on a distinct phenotype with favorable outcome following deep brain stimulation

L. Cif, V. Gonzalez Martinez, E. Sanrey, E. Nerrant, M. Ros, F. Cyprien, E. Chan Seng, T. Roujeau, P. Coubes (Montpellier, France)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Balance and gait disturbances in Parkinson’s disease patients with falls and freezing of gait

J. Stozek, M. Rudzinska, S. Bukowczan, A. Szczudlik (Cracow, Poland)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Balance training in individual’s with Parkinson’s disease: Therapist-supervised vs. home-based exercise programmes

E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Beliefs and knowledge on Parkinson’s disease (PD) among people with PD, the public and traditional healers in Western Cape, South Africa

J. Mokaya, J. Carr (Tygerberg, South Africa)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Best supportive care or palliative care for late stage Parkinsonian syndromes?

S. Lorenzl, C. Richinger, C. Schmotz, G. Nübling (Salzburg, Austria)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Beta – blockers worsen vascular parkinsonism in patients with concomitant coronary heart disease

A. Turakhonov, S. Dadajonov, R. Sadikov, R. Khodjaev, S. Nurov (Tashkent, Uzbekistan)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2